![](/img/cover-not-exists.png)
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin
Jürgen V Smit, Elke M.G.J de Jong, Candida A.E.M van Hooijdonk, Marisol E Otero, Jan B.M Boezeman, Peter C.M van de KerkhofVolume:
51
Year:
2004
Language:
english
DOI:
10.1016/j.jaad.2004.03.002
File:
PDF, 423 KB
english, 2004